Literature DB >> 4812768

Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer.

L H Baker, C B Vaughn, M al-Sarraf, M L Reed, V K Vaitkevicius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812768     DOI: 10.1002/1097-0142(197402)33:2<513::aid-cncr2820330228>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Selecting dose-intense drug combinations: metastatic breast cancer.

Authors:  E L Korn; R Simon
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

Review 2.  Update on cancer chemotherapy: general considerations and breast cancer. Part II.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-09       Impact factor: 1.798

Review 3.  Postmenopausal breast cancer. Drug therapy in the 1990s.

Authors:  C I Falkson; G Falkson; H C Falkson
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

Review 4.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

5.  Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group.

Authors:  R T Chlebowski; R V Smalley; J M Weiner; L E Irwin; A A Bartolucci; J R Bateman
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

6.  Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination.

Authors:  R D Rubens; R K Knight; J L Hayward
Journal:  Br J Cancer       Date:  1975-12       Impact factor: 7.640

Review 7.  Combination versus sequential single agent chemotherapy for metastatic breast cancer.

Authors:  Rachel F Dear; Kevin McGeechan; Marisa C Jenkins; Alexandra Barratt; Martin H N Tattersall; Nicholas Wilcken
Journal:  Cochrane Database Syst Rev       Date:  2013-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.